Videos

Hope S. Rugo, MD, director of Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the DigniCap cooling system to reduce the severity and frequency of hair loss in patients receiving chemotherapy for breast cancer.

C. Ola Landgren, MD, PhD, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses treating smoldering multiple myeloma.

William Wierda, MD, PhD, medical director, Leukemia Center, The University of Texas MD Anderson Cancer Center, discusses treatment of chronic lymphocytic leukemia (CLL) in young and elderly patients.

Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission. 

Mark Kris, MD, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses the benefits of new therapies for lung cancer. 

Benjamin Levy, MD, medical director, Thoracic Oncology, Mount Sinai Health System, discusses recent advances in the detection and diagnosis of lung cancer.

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses how a mobile app can help oncology professionals monitor patients for melanoma.

Phyllis McKiernan, MSN, APN, OCN, nurse practitioner, John Theurer Cancer Center at Hackensack University Medical Center, discusses new drug approvals for multiple myeloma and addressing adverse events. 

Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses the role of non-physician providers in gynecologic oncology. 

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.

Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin to treat patients with soft tissue sarcoma. 

David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses caring for patients with glioblastoma.

Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses new agents that were recently approved for multiple myeloma.

Jeffrey Jones, MD, MPH, assistant professor of Internal Medicine and section head of the Chronic Lymphocytic Leukemia (CLL) research program at Ohio State University Comprehensive Cancer Center, discusses how nurses can help patients comply with taking their oncology drugs.

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.

Roger Lo, MD, PhD, UCLA Jonsson Comprehensive Cancer Center, discusses the evolution of metastatic melanoma during therapy.

Jennifer Montes, MD, New York University Medical Center, discusses the role of nurses in treating patients with breast cancer.

Mabel Ryder, MD, endocrinologist and medical oncologist, Mayo Clinic, discusses targeting the tumor microenvironment in thyroid cancer. 

Richard Joseph, MD, an oncologist at Mayo Clinic, discusses mucosal melanoma.

John Kirkwood, MD, Usher professor, Medicine, Dermatology and Translational Science, co-director, Melanoma and Skin Cancer Program, University of Pittsburgh, discusses training physicians on skin examinations for detecting melanoma. 

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses the mobile app Mole Mapper, which allows patients to measure and monitor their moles for melanoma.

Anita Nirenberg, PhD, RN, AOCNP, PNP-BC, FAAN, a professor of clinical nursing and associate director for Nurse Practitioner Specialties at Hunter-Bellevue School of Nursing, discusses pediatric oncology nursing.

Jennifer Temel, MD, clinical director of thoracic oncology at Massachusetts General Hospital, discusses screening for pain and other cancer-related symptoms.

Charles Loprinzi, MD, Giant of Cancer Care: Supportive/Palliative Care, Mayo Clinic, discusses potential treatments for chemotherapy-induced peripheral neuropathy (CIPN).

Aaron Spitz, MD, Orange County Urology Associates, discusses how telemedicine is expanding nurses' roles and responsibilities in caring for patients.

Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses caregiver burden in spouses of patients with lung cancer.

Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses patients' needs for palliative care in gynecologic oncology. 

Rudolph Navari, MD, PhD, professor of Medicine at Indiana University School of Medicine -South Bend, discusses traditional antiemetic treatment for chemotherapy-induced nausea and vomiting (CINV).